Drug intelligence / Profile preview

gastrin siRNA polyplex

Development stage
Unknown
Lead developer
Georgetown University School of Medicine
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous
01

Overview

A **gastrin siRNA polyplex** is a therapeutic nanoparticle formulation that complexes small interfering RNA (siRNA) targeting the **gastrin gene** with a cationic polymer to form a polyplex (micellar nanoparticle). This drug is designed to selectively deliver gastrin-targeting siRNA to tumors that overexpress the **cholecystokinin B (CCK-B) receptor**, notably in pancreatic ductal adenocarcinoma (PDAC). Upon cellular uptake mediated by CCK-B receptor targeting, the siRNA is released in tumor cells, resulting in **gene knockdown of gastrin**, leading to reduced peptide expression, inhibition of tumor growth, and block of metastasis in preclinical PDAC models. This approach minimizes off-target toxicity and achieves efficient, tumor-selective gene silencing[1].

Other names
gastrin-targeted siRNA polyplexcholecystokinin receptor-targeted gastrin siRNA nanoparticlegastrin siRNA-loaded polyplex nanoparticlegastrin siRNA NP
02

Targets

CCK2R (Cholecystokinin 2 Receptor)

Beyond the preview

Go deeper on gastrin siRNA polyplex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gastrin siRNA polyplex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call